Indication
Bacterial Conjunctivitis
1 clinical trial
2 products
Product
IVIEW-1201Product
OfloxacinClinical trial
A Phase II, Multi-Center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW 1201 Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial ConjunctivitisStatus: Completed, Estimated PCD: 2023-09-13